We found that a high NEDI was strongly correlated with somatic mutations in the TP53 and RB1 genes and tobacco carcinogens, which have been reported to be associated with the development of SCLC, the most common form of neuroendocrine lung cancer. This evidence concerns the gene RB1 and small cell lung carcinoma.